Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$974M |
| 2 |
Apple
AAPL
|
+$780M |
| 3 |
Amazon
AMZN
|
+$768M |
| 4 |
Kenvue
KVUE
|
+$659M |
| 5 |
Blackstone
BX
|
+$597M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$413M |
| 2 |
Texas Instruments
TXN
|
+$219M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$202M |
| 4 |
Pfizer
PFE
|
+$192M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$145M |
Sector Composition
| 1 | Technology | 27.72% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 12.45% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Hyperfine
HYPR
$113M
| $985K | ﹤0.01% |
480,253
+56,521
| +13% | +$116K |
|
3327
OP Bancorp
OPBK
$216M
| $983K | ﹤0.01% |
107,437
+828
| +0.8% | +$7.58K |
|
3328
Galectin Therapeutics
GALT
$373M
| $980K | ﹤0.01% |
510,431
-11,855
| -2% | -$22.8K |
|
3329
Anixa Biosciences
ANIX
$96.3M
| $980K | ﹤0.01% |
299,646
-3,372
| -1% | -$11K |
|
3330
Quest Resource Holding
QRHC
$34.6M
| $976K | ﹤0.01% |
131,829
+271
| +0.2% | +$2.01K |
|
3331
Sagimet Biosciences
SGMT
$227M
| $974K | ﹤0.01% |
+110,701
| New | +$974K |
|
|
DZSI
3332
DELISTED
DZS Inc. Common Stock
DZSI
| $973K | ﹤0.01% |
463,298
+11,470
| +3% | +$24.1K |
|
|
AVDL
3333
Avadel Pharmaceuticals
AVDL
$1.53B
| $972K | ﹤0.01% |
94,405
+14,003
| +17% | +$144K |
|
3334
Acme United Corp
ACU
$162M
| $970K | ﹤0.01% |
32,439
+441
| +1% | +$13.2K |
|
3335
Value Line
VALU
$360M
| $967K | ﹤0.01% |
22,122
+999
| +5% | +$43.7K |
|
|
HYPD
3336
Hyperion DeFi, Inc. Common Stock
HYPD
$65M
| $967K | ﹤0.01% |
7,278
+335
| +5% | +$44.5K |
|
3337
Apyx Medical
APYX
$77.2M
| $965K | ﹤0.01% |
301,518
-10,723
| -3% | -$34.3K |
|
|
BHIL
3338
DELISTED
Benson Hill, Inc.
BHIL
| $964K | ﹤0.01% |
83,038
+680
| +0.8% | +$7.89K |
|
3339
Northern Technologies International Corp
NTIC
$74M
| $962K | ﹤0.01% |
71,923
+7,085
| +11% | +$94.8K |
|
3340
Ero Copper
ERO
$1.77B
| $961K | ﹤0.01% |
49,553
+18,159
| +58% | +$352K |
|
3341
AEON Biopharma
AEON
$9.15M
| $960K | ﹤0.01% |
2,380
+2,175
| +1,061% | +$877K |
|
3342
Beam Global
BEEM
$41.1M
| $959K | ﹤0.01% |
129,956
+39,534
| +44% | +$292K |
|
|
MDV
3343
Modiv Industrial
MDV
$151M
| $958K | ﹤0.01% |
62,138
+1,960
| +3% | +$30.2K |
|
3344
Urban One Class A
UONE
$64.4M
| $954K | ﹤0.01% |
190,022
+1,195
| +0.6% | +$6K |
|
3345
Heritage Global
HGBL
$65.7M
| $952K | ﹤0.01% |
304,930
+23,585
| +8% | +$73.6K |
|
3346
Amprius Technologies
AMPX
$1.03B
| $951K | ﹤0.01% |
200,669
+37,531
| +23% | +$178K |
|
3347
Esperion Therapeutics
ESPR
$571M
| $951K | ﹤0.01% |
970,238
+146,731
| +18% | +$144K |
|
|
NGM
3348
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $949K | ﹤0.01% |
886,901
+35,945
| +4% | +$38.5K |
|
3349
Iris Energy
IREN
$8.95B
| $942K | ﹤0.01% |
254,023
+36,618
| +17% | +$136K |
|
3350
Calumet Specialty Products
CLMT
$1.5B
| $941K | ﹤0.01% |
49,250
-4,841
| -9% | -$92.5K |
|